National Health Investors (NYSE:NHI - Get Free Report) had its price target boosted by stock analysts at Truist Financial from $76.00 to $77.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a "hold" rating on the real estate investment trust's stock. Truist Financial's price objective suggests a potential upside of 7.47% from the stock's previous close.
Separately, Wedbush reissued an "outperform" rating and issued a $88.00 price target on shares of National Health Investors in a research report on Monday, March 17th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, National Health Investors currently has an average rating of "Hold" and an average price target of $85.75.
View Our Latest Stock Report on NHI
National Health Investors Stock Up 0.4%
NHI stock traded up $0.25 during midday trading on Monday, hitting $71.65. The company's stock had a trading volume of 215,894 shares, compared to its average volume of 239,555. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 52-week low of $65.13 and a 52-week high of $86.13. The firm has a market capitalization of $3.35 billion, a P/E ratio of 24.62, a PEG ratio of 4.42 and a beta of 0.75. The firm has a 50-day simple moving average of $73.69 and a 200-day simple moving average of $72.01.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $68.87 million during the quarter, compared to analysts' expectations of $85.13 million. During the same quarter last year, the company posted $1.10 EPS. The firm's revenue was up 9.6% compared to the same quarter last year. As a group, equities analysts forecast that National Health Investors will post 4.41 EPS for the current year.
Institutional Investors Weigh In On National Health Investors
Several institutional investors have recently modified their holdings of NHI. Norges Bank purchased a new stake in shares of National Health Investors during the 4th quarter worth $42,322,000. Millennium Management LLC lifted its position in shares of National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock worth $33,843,000 after purchasing an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of National Health Investors during the 4th quarter worth $23,917,000. Marshall Wace LLP lifted its position in shares of National Health Investors by 161.6% during the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock worth $38,225,000 after purchasing an additional 340,712 shares during the last quarter. Finally, Land & Buildings Investment Management LLC lifted its position in shares of National Health Investors by 109.4% during the 4th quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock worth $32,367,000 after purchasing an additional 243,999 shares during the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.
National Health Investors Company Profile
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.